These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 18028029)

  • 1. Cytochrome P450/redox partner fusion enzymes: biotechnological and toxicological prospects.
    McLean KJ; Girvan HM; Munro AW
    Expert Opin Drug Metab Toxicol; 2007 Dec; 3(6):847-63. PubMed ID: 18028029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytochrome P450--redox partner fusion enzymes.
    Munro AW; Girvan HM; McLean KJ
    Biochim Biophys Acta; 2007 Mar; 1770(3):345-59. PubMed ID: 17023115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytochromes P450 as promising catalysts for biotechnological application: chances and limitations.
    Bernhardt R; Urlacher VB
    Appl Microbiol Biotechnol; 2014; 98(14):6185-203. PubMed ID: 24848420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant human cytochrome P450 monooxygenases for drug metabolite synthesis.
    Schroer K; Kittelmann M; Lütz S
    Biotechnol Bioeng; 2010 Aug; 106(5):699-706. PubMed ID: 20506361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Versatile biocatalysis of fungal cytochrome P450 monooxygenases.
    Durairaj P; Hur JS; Yun H
    Microb Cell Fact; 2016 Jul; 15(1):125. PubMed ID: 27431996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineering cytochrome P450 enzyme systems for biomedical and biotechnological applications.
    Li Z; Jiang Y; Guengerich FP; Ma L; Li S; Zhang W
    J Biol Chem; 2020 Jan; 295(3):833-849. PubMed ID: 31811088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards engineered topogenesis of cytochrome b(5) and P450 for in vivo transformation of xenobiotics.
    Kaderbhai MA; Kelly SL; Kaderbhai NN
    Biochem Soc Trans; 2006 Dec; 34(Pt 6):1231-5. PubMed ID: 17073792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chimeric cytochromes P450 engineered by domain swapping and random mutagenesis for producing human metabolites of drugs.
    Kang JY; Ryu SH; Park SH; Cha GS; Kim DH; Kim KH; Hong AW; Ahn T; Pan JG; Joung YH; Kang HS; Yun CH
    Biotechnol Bioeng; 2014 Jul; 111(7):1313-22. PubMed ID: 24474032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chimeric P450 enzymes: activity of artificial redox fusions driven by different reductases for biotechnological applications.
    Sadeghi SJ; Gilardi G
    Biotechnol Appl Biochem; 2013; 60(1):102-10. PubMed ID: 23586997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytochrome P450 Enzymes and Drug Metabolism in Humans.
    Zhao M; Ma J; Li M; Zhang Y; Jiang B; Zhao X; Huai C; Shen L; Zhang N; He L; Qin S
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural modelling of the human drug-metabolizing cytochromes P450.
    Lewis DF; Ito Y; Goldfarb PS
    Curr Med Chem; 2006; 13(22):2645-52. PubMed ID: 17017916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural insights into understudied human cytochrome P450 enzymes.
    Machalz D; Pach S; Bermudez M; Bureik M; Wolber G
    Drug Discov Today; 2021 Oct; 26(10):2456-2464. PubMed ID: 34161845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbial cytochromes P450: biodiversity and biotechnology. Where do cytochromes P450 come from, what do they do and what can they do for us?
    Kelly SL; Kelly DE
    Philos Trans R Soc Lond B Biol Sci; 2013 Feb; 368(1612):20120476. PubMed ID: 23297358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidation of 3-aminobenzanthrone, a human metabolite of carcinogenic environmental pollutant 3-nitrobenzanthrone, by cytochromes P450 - similarity between human and rat enzymes.
    Mizerovska J; Dracinska H; Arlt VM; Schmeiser HH; Frei E; Stiborova M
    Neuro Endocrinol Lett; 2009; 30 Suppl 1():52-9. PubMed ID: 20027145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Fluorescent Readout for the Oxidation State of Electron Transporting Proteins in Cell Free Settings.
    Pochekailov S; Black RR; Chavali VP; Khakhar A; Seelig G
    ACS Synth Biol; 2016 Jul; 5(7):662-71. PubMed ID: 27049848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of inhibitory and regulatory effects of methylenedioxyphenyl compounds on cytochrome P450-dependent drug oxidation.
    Murray M
    Curr Drug Metab; 2000 Jul; 1(1):67-84. PubMed ID: 11467081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological diversity of cytochrome P450 redox partner systems.
    McLean KJ; Luciakova D; Belcher J; Tee KL; Munro AW
    Adv Exp Med Biol; 2015; 851():299-317. PubMed ID: 26002740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro assessment of the allelic variants of cytochrome P450.
    Hiratsuka M
    Drug Metab Pharmacokinet; 2012; 27(1):68-84. PubMed ID: 22041138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterization of specifically active recombinant fused enzymes consisting of CYP3A4, NADPH-cytochrome P450 oxidoreductase, and cytochrome b5.
    Inui H; Maeda A; Ohkawa H
    Biochemistry; 2007 Sep; 46(35):10213-21. PubMed ID: 17691855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytochrome P450 biodiversity and biotechnology.
    Kelly SL; Lamb DC; Kelly DE
    Biochem Soc Trans; 2006 Dec; 34(Pt 6):1159-60. PubMed ID: 17073775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.